Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts.

Source:http://linkedlifedata.com/resource/pubmed/id/18236404

Download in:

View as

General Info

PMID
18236404